|
 |
Faculty |
 |
Statement of Need |
 |
Activity Goal |
 |
Learning Objectives |
 |
Financial Support |
 |
Target Audience |
 |
Credit Information |
Restless Legs Syndrome (RLS)
neuroscienceCME Multimedia Snack
Premiere Date: Friday, April 27, 2012This activity offers CE credit for:
- Physicians (CME)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, April 27, 2013
Note: Credit Is No Longer Available
 | Ned H. Kalin, MD Hedberg Professor and Chair Department of Psychiatry University of Wisconsin School of Medicine and Public Health--Madison Director, HealthEmotions Research Institute Madison, WI Editor-in-Chief – American Journal of Psychiatry |
 | W. Vaughn McCall, MD, MS Case Distinguished University Chair Department of Psychiatry and Health Behavior Executive Vice Dean Medical College of Georgia Augusta University Augusta, GA |
Co-provided by
Restless legs syndrome (RLS) is a movement disorder with negative effects on sleep and daytime activities that affect personal, family, and occupational life. The overall impact of RLS on quality of life is comparable to that of chronic conditions such as depression and diabetes. In addition, misdiagnosis and inappropriate treatment can increase patients' discomfort and pain, leading to overuse of clinical care services.
This neuroscienceCME Snack provides an overview of RLS, emphasizing the salient features that help clinicians accurately detect and promptly treat it, when appropriate.
To provide evidence-based content that enables clinicians who encounter patients with suspected or probable RLS to be able to improve diagnosis and treatment of RLS, in accordance with the identified, gaps-based learning objectives for the activity.
At the end of this CE activity, participants should be able to:
- Query patients presenting with sleep complaints about the symptoms of restless legs syndrome.
- Diagnose and treat restless legs syndrome in accordance with established diagnostic criteria and treatment recommendations.
USF Health and CME Outfitters, LLC, gratefully acknowledge an educational grant from Genentech in support of this activity.
This activity is supported by an educational grant from UCB.
This educational activity is supported by an independent medical education grant from Shire.
Physicians and nonphysician health care professionals who provide clinical care to patients who are likely to present with sleep complaints, either alone or within the context of other neurological or psychiatric symptoms.
CME Credit (Physicians):
USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure of Relevant Financial Relationships with Commercial Interests
USF Health and CME Outfitters, LLC, adhere to the ACCME Standards, as well as those of the ACPE, APA, and ANCC, regarding commercial support of continuing medical education. It is the policy of USF Health and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
USF Health and CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Kalin has disclosed that he serves on the advisory boards of CeNeRx BioPharma; CME Outfitters, LLC; Corcept Therapeutics; Elsevier; Janssen L.P.; and Letters & Sciences. He is a stockholder of/has equity options in CeNeRx BioPharma and Corcept Therapeutics. Dr. Kalin is the owner of Promoter Neurosciences, LLC, and holds patents for the following: promoter sequences for corticotropin-releasing factor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences (U.S. Patent issued on 07-04-06; patent #7071323, U.S. Patent issued on 05-12-09; patent #7,531,356); promoter sequences for urocortin II and the use thereof (U.S. Patent issued on 08-08-06; patent #7087385); and promoter sequences for corticotropin-releasing factor binding protein and use thereof (U.S. Patent issued on 10-17-06; patent #7122650).
Dr. McCall has disclosed that he receives grants/research support from Cephalon, Inc., and Mini Mitter. He serves on the advisory boards of Merck & Co., Inc, Sealy Corporation, and Sepracor Inc., and on the speakers bureaus of Merck & Co., Inc., and Sepracor Inc.
Disclosures were obtained from the planning committee members and are on file in the USF Health Office of Continuing Professional Development (OCPD) for review. Disclosures were obtained from the USF Health OCPD staff: Nothing to Disclose.
Howard Bliwise, MD (Content/peer reviewer) has no disclosures to report.
Monique Johnson, MD, CCMEP (planning committee) has no disclosures to report.
Sandra Haas Binford, MEd (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Joy B. Leffler, MLA, NASW (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CME activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
USF Health, CME Outfitters, LLC, the faculty, Genentech, UCB, and Shire Pharmaceuticals do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Equal Opportunity Statement:
Events, activities, programs and facilities of the University of South Florida are available to all without regard to race, color, marital status, gender, sexual orientation, religion, national origin, disability, age, Vietnam or disabled veteran status as provided by law and in accordance with the university's respect for personal dignity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
SN-042-042712-90
